Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,033,598
+$64,804 QoQ
Shares Held
12,976
+0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#424
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $156,508,696 across 14 Drug Manufacturers - General names. NVS ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
170,334 | $43,259,725 | |
| 2 | LLY |
ELI LILLY & Co
|
33,088 | $39,686,743 | |
| 3 | ABBV |
AbbVie Inc.
|
155,264 | $39,070,632 | |
| 4 | MRK |
Merck & Co., Inc.
|
96,505 | $12,400,892 | |
| 5 | AMGN |
Amgen Inc
|
23,570 | $8,535,168 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
93,509 | $5,387,988 | |
| 7 | PFE |
Pfizer Inc
|
100,100 | $2,410,408 | |
| 8 | NVS |
Novartis AG
This page
|
12,976 | $2,033,598 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,033,598 | 12,976 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,968,794 | 12,889 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,063,362 | 14,966 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,919,239 | 14,966 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,263,613 | 18,706 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,129,936 | 19,106 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,779,799 | 18,290 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,132,470 | 18,540 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,044,457 | 19,204 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,845,801 | 19,082 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,887,634 | 18,695 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,760,446 | 17,283 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,640,090 | 16,253 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,491,872 | 16,216 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,502,413 | 16,561 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,041,032 | 13,696 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,138,619 | 13,470 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,165,144 | 13,278 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,204,024 | 13,765 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,124,720 | 13,753 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,264,403 | 13,858 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,187,402 | 13,891 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,327,780 | 14,061 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,189,438 | 13,678 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,203,021 | 13,774 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,147,456 | 13,917 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||